- UNIDAD DE CIRUGÍA ARTROSCÓPICA
- UCA INFANTIL
- SERVICIOS
- PATOLOGÍAS
- INVESTIGACIÓN
- NOTICIAS
La Unidad de Cirugía Artroscópica cuenta con más de 70 publicaciones tanto en investigación básica como en investigación clínica y divulgación científica para contribuir al desarrollo de la medicina basada en la evidencia, en el ámbito de los tratamientos con plasma en las lesiones del aparato locomotor.
El objetivo final de las investigaciones es mejorar la calidad de vida de los pacientes y divulgar la experiencia en el ámbito médico para que pueda ser contrastada y utilizada por otros profesionales de la medicina.
Comment on moving toward targeting the right phenotype with the right platelet-rich plasma formulation for knee osteoarthritis
Sánchez M, Delgado D.
Ther Adv Musculoskelet Dis. 2021 Jun 3;13:1759720X211019531.
Response to the letter to the editor concerning the article “Platelet-rich plasma for the treatment of knee osteoarthritis: an expert opinion and proposal for a novel classification and coding system”
Di Matteo B, Kon E, Delgado D, Sánchez M
Expert Opinion on Biological Therapy
Towards a correct timing and dosage in PRP applications
Padilla S, Sánchez M, Orive G, Anitua E.
Injury. 2015 Aug;46(8):1697-8.
Platelet Rich Plasma and Orthopedics: Why, When, and How
Mikel Sánchez, Giuseppe Filardo, Tomokazu Yoshioka
BioMed Research International Volume 2015, Article ID 949720
When the capsule matters
Fiz N
Ann Transl Med. 2015 May;3(Suppl 1):S30.
Platelet-rich plasma in orthopaedic applications: evidence-based recommendations for treatment
Padilla S, Orive G, Sanchez M, Anitua E, Hsu WK
J Am Acad Orthop Surg. 2014 Aug;22(8):469-70
More on platelet-rich plasma injections in acute muscle injury
Anitua E, Sánchez M, Padilla S
N Engl J Med. 2014 Sep 25;371(13):1264.
A biological approach to orthopaedic surgery: are they lost in translation?
Sánchez M, Anitua E, Orive G, Padilla S.
Arthroscopy. 2013 Jun;29(6):969-70.
Causality in biology has to answer 2 main questions--which and how: letter to the editor.
Padilla S, Orive G, Sánchez M, Anitua E, Wasterlain AS, Dragoo JL.
Am J Sports Med. 2013 May;41(5):NP22-3.
We cannot take oranges for apples in the field of platelet-rich plasma products.
Anitua E, Sánchez M.
Scand J Med Sci Sports. 2012 Apr;22(2):147-8
The type of platelet-rich plasma may influence the safety of the approach.
Anitua E, Sánchez M, Prado R, Orive G.
Knee Surg Sports Traumatol Arthrosc. 2012.
Plasma rich in growth factors: the pioneering autologous technology for tissue regeneration.
Anitua E, Sánchez M, Prado R, Orive G.
J Biomed Mater Res A. 2011 Jun 15;97(4):536.
The P makes the difference in plasma rich in growth factors (PRGF) technology.
Anitua E, Sánchez M, Prado R, Orive G.
Platelets. 2011;22(6):473-4; author reply 475.
The importance of understanding what is platelet-rich growth factor (PRGF) and what is not.
Anitua E, Sánchez M, Orive G.
J Shoulder Elbow Surg. 2011 Jan;20(1):e23-4; author reply e24.
Poor standardization in platelet-rich therapies hampers advancement.
Sánchez M, Anitua E, Andia I.
Arthroscopy. 2010 Jun;26(6):725-6; author reply 726.
Shedding light in the controversial terminology for platelet rich products.
Anitua E, Sánchez M, Orive G, Andía I.
J Biomed Mater Res A. 2009 Sep 15;90(4):1262-3